{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:17:38Z","timestamp":1794539858270,"version":"4.9.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"36","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Atrial fibrillation (AF) is frequently classified by episode duration and cumulative burden, yet these methods fail to characterize temporal episode distribution (AF density), which may be more clinically relevant and prognostically important. This study evaluated AF density\u2019s association with ischaemic stroke and whether it improves risk stratification compared with AF burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from two US cohorts with cardiac implantable electronic devices remotely monitored by the Veterans Health Administration and University of North Carolina (January 2010\u2013May 2025) were analysed. AF burden (percentage of time in AF) and density [range: 0 (dispersed episodes) to 1 (consolidated episodes)] were assessed in 30-day intervals and categorized as low (&amp;gt;0\u20130.3), medium (&amp;gt;0.3\u20130.6), medium-high (&amp;gt;0.6\u20130.9), and high (&amp;gt;0.9\u20131.0). Patients with permanent AF or no episodes \u22656 min were excluded. G-formula modelling estimated 1-year stroke risk ratios (RRs), adjusting for baseline and time-varying covariates. Results were pooled using random-effects meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 41 780 patients, 12 868 met inclusion criteria (mean age 72.0 years; median CHA2DS2-VASc 4.0); 336 experienced ischaemic stroke over a median 4.0-year follow-up (6.3 per 1000 person-years). Atrial fibrillation density demonstrated a dose\u2013response relationship with 1-year stroke risk (RR 1.75; 95% confidence interval 1.25\u20132.44) and findings were consistent across device types, comorbidities, age, and anticoagulation status. At each level of AF burden, patients with high density exhibited greater stroke risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Atrial fibrillation density demonstrated robust dose\u2013response relationships with ischaemic stroke independent of AF burden and enhanced risk stratification, suggesting that density may enable more precise stroke risk assessment and personalized prevention strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehag203","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:01:27Z","timestamp":1774656087000},"page":"5112-5124","source":"Crossref","is-referenced-by-count":8,"title":["Atrial fibrillation density as a biomarker for ischaemic stroke risk prediction"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0944-6864","authenticated-orcid":false,"given":"Lindsey","family":"Rosman","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Cardiology, University of North Carolina at Chapel Hill , Chapel Hill, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaicheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiology, University of North Carolina at Chapel Hill , Chapel Hill, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shantanu","family":"Sarkar","sequence":"additional","affiliation":[{"name":"Medtronic, Inc. , Minneapolis, MN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D","family":"Ziegler","sequence":"additional","affiliation":[{"name":"Medtronic, Inc. , Minneapolis, MN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8718-1534","authenticated-orcid":false,"given":"Rod S","family":"Passman","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Feinberg School of Medicine, Northwestern University , 676 N St Claire, Suite 600, Chicago, IL 60611 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"2026092119583936900_ehag203-B1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026092119583936900_ehag203-B2","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/CIRCULATIONAHA.109.192667","article-title":"Heart disease and stroke statistics\u20132010 update: a report from the American Heart Association","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"2026092119583936900_ehag203-B3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"2026092119583936900_ehag203-B4","doi-asserted-by":"publisher","first-page":"e623","DOI":"10.1161\/CIR.0000000000000568","article-title":"Atrial fibrillation burden: moving beyond atrial fibrillation as a binary entity: a scientific statement from the American Heart Association","volume":"137","author":"Chen","year":"2018","journal-title":"Circulation"},{"key":"2026092119583936900_ehag203-B5","doi-asserted-by":"publisher","first-page":"euaf019","DOI":"10.1093\/europace\/euaf019","article-title":"Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology council on stroke and the European heart rhythm association","volume":"27","author":"Doehner","year":"2025","journal-title":"Europace"},{"key":"2026092119583936900_ehag203-B6","doi-asserted-by":"publisher","first-page":"e012394","DOI":"10.1161\/CIRCEP.123.012394","article-title":"Performance of atrial fibrillation burden trends for stroke risk stratification","volume":"17","author":"Piccini","year":"2024","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026092119583936900_ehag203-B7","doi-asserted-by":"publisher","first-page":"e005595","DOI":"10.1161\/CIRCOUTCOMES.118.005595","article-title":"Atrial fibrillation burden signature and near-term prediction of stroke","volume":"12","author":"Han","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026092119583936900_ehag203-B8","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1016\/j.jacep.2024.06.020","article-title":"Associations between changes in maximum daily atrial fibrillation duration, ischemic stroke, and mortality","volume":"10","author":"Peigh","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"2026092119583936900_ehag203-B9","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1056\/NEJMoa0803778","article-title":"Effect of dronedarone on cardiovascular events in atrial fibrillation","volume":"360","author":"Hohnloser","year":"2009","journal-title":"N Engl J Med"},{"key":"2026092119583936900_ehag203-B10","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"key":"2026092119583936900_ehag203-B11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"key":"2026092119583936900_ehag203-B12","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/eurheartj\/eht491","article-title":"Device-detected atrial fibrillation and risk for stroke: an analysis of &gt;10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices)","volume":"35","author":"Boriani","year":"2014","journal-title":"Eur Heart J"},{"key":"2026092119583936900_ehag203-B13","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1161\/CIRCULATIONAHA.112.098079","article-title":"A comprehensive evaluation of rhythm monitoring strategies for the detection of atrial fibrillation recurrence","volume":"126","author":"Charitos","year":"2012","journal-title":"Circulation"},{"key":"2026092119583936900_ehag203-B14","doi-asserted-by":"publisher","first-page":"e020559","DOI":"10.1161\/JAHA.120.020559","article-title":"Arrhythmia risk during the 2016 US presidential election: the cost of stressful politics","volume":"10","author":"Rosman","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2026092119583936900_ehag203-B15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/pace.14409","article-title":"Immediate and long-term effects of the COVID-19 pandemic and lockdown on physical activity in patients with implanted cardiac devices","volume":"45","author":"Rosman","year":"2022","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026092119583936900_ehag203-B16","volume-title":"Linking Data for Health Services Research: A Framework and Instructional Guide","author":"Dusetzina","year":"2014"},{"key":"2026092119583936900_ehag203-B17","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1001\/jamaneurol.2023.3931","article-title":"Atrial fibrillation in patients with stroke attributed to large- or small-vessel disease: 3-year results from the STROKE AF randomized clinical trial","volume":"80","author":"Bernstein","year":"2023","journal-title":"JAMA Neurol"},{"key":"2026092119583936900_ehag203-B18","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1093\/europace\/eul112","article-title":"Verification of pacemaker automatic mode switching for the detection of atrial fibrillation and atrial tachycardia with Holter recording","volume":"8","author":"de Voogt","year":"2006","journal-title":"Europace"},{"key":"2026092119583936900_ehag203-B19","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1111\/j.1540-8159.2004.00569.x","article-title":"Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies","volume":"27","author":"Purerfellner","year":"2004","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026092119583936900_ehag203-B20","doi-asserted-by":"publisher","first-page":"f321","DOI":"10.1093\/europace\/eux272","article-title":"Adapting detection sensitivity based on evidence of irregular sinus arrhythmia to improve atrial fibrillation detection in insertable cardiac monitors","volume":"20","author":"P\u00fcrerfellner","year":"2018","journal-title":"Europace"},{"key":"2026092119583936900_ehag203-B21","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1161\/01.CIR.101.8.878","article-title":"Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator. For the worldwide jewel AF investigators","volume":"101","author":"Swerdlow","year":"2000","journal-title":"Circulation"},{"key":"2026092119583936900_ehag203-B22","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1161\/STROKEAHA.115.009930","article-title":"New appraisal of atrial fibrillation burden and stroke prevention","volume":"47","author":"Passman","year":"2016","journal-title":"Stroke"},{"key":"2026092119583936900_ehag203-B23","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1001\/jamacardio.2018.1176","article-title":"Association of burden of atrial fibrillation with risk of ischemic stroke in adults with paroxysmal atrial fibrillation: the KP-RHYTHM study","volume":"3","author":"Go","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2026092119583936900_ehag203-B24","doi-asserted-by":"publisher","first-page":"107214","DOI":"10.1016\/j.cct.2023.107214","article-title":"Ascertainment of stroke from administrative data to support a pragmatic embedded clinical trial","volume":"130","author":"Raju","year":"2023","journal-title":"Contemp Clin Trials"},{"key":"2026092119583936900_ehag203-B25","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"key":"2026092119583936900_ehag203-B26","doi-asserted-by":"publisher","first-page":"100008","DOI":"10.1016\/j.patter.2020.100008","article-title":"gfoRmula: an R package for estimating the effects of sustained treatment strategies via the parametric g-formula","volume":"1","author":"McGrath","year":"2020","journal-title":"Patterns (N Y)"},{"key":"2026092119583936900_ehag203-B27","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1093\/eurjpc\/zwad240","article-title":"Hypothetical interventions and risk of atrial fibrillation by sex and education: application of the parametric g-formula in the Troms\u00f8 study","volume":"30","author":"Nilsen","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"2026092119583936900_ehag203-B28","doi-asserted-by":"publisher","first-page":"e013011","DOI":"10.1161\/JAHA.119.013011","article-title":"Refining the association between body mass index and atrial fibrillation: G-formula and restricted mean survival times","volume":"8","author":"Conner","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2026092119583936900_ehag203-B29","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jacep.2016.01.015","article-title":"Patient activity decreases and mortality increases after the onset of persistent atrial fibrillation in patients with implantable cardioverter-defibrillators","volume":"2","author":"Chelu","year":"2016","journal-title":"JACC Clin Electrophysiol"},{"key":"2026092119583936900_ehag203-B30","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1161\/CIRCULATIONAHA.119.041303","article-title":"Stroke risk as a function of atrial fibrillation duration and CHA2DS2-VASc score","volume":"140","author":"Kaplan","year":"2019","journal-title":"Circulation"},{"key":"2026092119583936900_ehag203-B31","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","article-title":"Anticoagulation with edoxaban in patients with atrial high-rate episodes","volume":"389","author":"Kirchhof","year":"2023","journal-title":"N Engl J Med"},{"key":"2026092119583936900_ehag203-B32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa2310234","article-title":"Apixaban for stroke prevention in subclinical atrial fibrillation","volume":"390","author":"Healey","year":"2024","journal-title":"N Engl J Med"},{"key":"2026092119583936900_ehag203-B33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0140-6736(09)60040-4","article-title":"Mechanisms of thrombogenesis in atrial fibrillation: Virchow\u2019s triad revisited","volume":"373","author":"Watson","year":"2009","journal-title":"Lancet"},{"key":"2026092119583936900_ehag203-B34","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.hrthm.2024.11.012","article-title":"Atrial fibrillation nomenclature, definitions, and mechanisms: position paper from the international working group of the signal summit","volume":"22","author":"de Groot","year":"2025","journal-title":"Heart Rhythm"},{"key":"2026092119583936900_ehag203-B35","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.19102\/icrm.2017.080104","article-title":"Monitoring for AF: identifying the burden of atrial fibrillation and assessing post-ablation","volume":"8","author":"Passman","year":"2017","journal-title":"J Innov Card Rhythm Manag"},{"key":"2026092119583936900_ehag203-B36","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1093\/eurheartj\/ehae373","article-title":"Atrial fibrillation burden: a new outcome predictor and therapeutic target","volume":"45","author":"Becher","year":"2024","journal-title":"Eur Heart J"},{"key":"2026092119583936900_ehag203-B37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12874-015-0091-1","article-title":"Hartung-Knapp-Sidik-Jonkman approach and its modification for random-effects meta-analysis with few studies","volume":"15","author":"R\u00f6ver","year":"2015","journal-title":"BMC Med Res Methodol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/36\/5112\/67604415\/ehag203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/36\/5112\/67604415\/ehag203.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:58:45Z","timestamp":1790035125000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/47\/36\/5112\/8551535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":37,"journal-issue":{"issue":"36","published-online":{"date-parts":[[2026,3,28]]},"published-print":{"date-parts":[[2026,9,22]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag203","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9,21]]},"published":{"date-parts":[[2026,3,28]]}}}